We learned it was going to be a type C meeting in July. We guessed the time frame from that, added a month for minutes, added a month for COVID delays and we were pretty spot on from memory (give or take a month).
I don't think we know the latest advise from the FDA on CHF other than MSB discussing precedent of approvals on weaker data than what we have. I think it was only assumed that this was off the back of an FDA meeting.
The timeline for CHF may be very different to CLBP in terms of what to expect next.
Silviu Itescu The Legend, page-21
-
- There are more pages in this discussion • 860 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
0.035(3.21%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.13 | $1.07 | $3.910M | 3.535M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 27197 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 43578 | 3 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |